X-Shining™ Luciferase - 10 mg/mL aqueous solution with glycerol
CAS:61970-00-1
The improved, thermostable X-Shining Luciferase is suitable for any luciferin-luciferase-based assay using D-luciferin (dLuc) or …
Purity:
(Sds-Page) Min. 90%
Color and Shape:
Clear Liquid
Ref: 3D-BX174908
| 1ml | 1,456.00 € | |
| 100µl | 267.00 € | |
| 250µl | 529.00 € | |
| 500µl | 912.00 € | |
| 2500µl | 3,419.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ Luciferase, lyophilised
CAS:61970-00-1
Supplied as lyophilisate containing 1% w/w X-Shining™ Luciferase. The improved, thermostable X-Shining Luciferase is suitable …
Purity:
(Spec. Activity. U/Mg) Min. 10^7
Color and Shape:
Powder
Ref: 3D-BX180145
| 1g | 1,032.00 € | |
| 100mg | 196.00 € | |
| 250mg | 394.00 € | |
| 500mg | 638.00 € | |
| 2500mg | 2,285.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ all-in-one ATP Assay, Biosynth Patent WO 2021/176101
In a single vial and in a single step, the X-ShiningTM all-in-one ATP Assay provides …
Color and Shape:
Powder
Ref: 3D-EX180920
| 1piece | 133.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ AST base medium, Biosynth Patent WO 2021/176101
X-Shining Base Medium is the required media for performing any of the X-Shining AST (Antibiotic …
Color and Shape:
Powder
Ref: 3D-EX182068
| 1piece | 157.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ AST imipenem, Biosynth Patent WO 2021/176101
Antibiotic resistance of pathogenic bacteria is a rising threat to human health world-wide. For treatment …
Color and Shape:
Powder
Ref: 3D-EX182069
| 1piece | 196.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ AST cefotaxime, Biosynth Patent WO 2021/176101
Antibiotic resistance of pathogenic bacteria is a rising threat to human health world-wide. For treatment …
Color and Shape:
Powder
Ref: 3D-EX182070
| 1piece | 196.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ AST ampicillin, Biosynth Patent WO 2021/176101
Antibiotic resistance of pathogenic bacteria is a rising threat to human health world-wide. For treatment …
Color and Shape:
Powder
Ref: 3D-EX182071
| 1piece | 196.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ Luciferase, 10 mg/mL aqueous solution with glycerol
CAS:61970-00-1
The improved, thermostable X-ShiningTM Luciferase is suitable for any luciferin-luciferase-based assay using D-luciferin (dLuc) or …
Purity:
(Sds-Page) Min. 90%
Ref: 3D-L-8093
| 1ml | To inquire | |
| 100µl | To inquire | |
| 250µl | To inquire | |
| 500µl | To inquire | |
| 2500µl | To inquire |
Estimated delivery in United States, on Tuesday 14 May 2024
X-Shining™ Luciferase, lyophilised
CAS:61970-00-1
Supplied as lyophilisate containing 1% w/w X-Shining™ Luciferase. The improved, thermostable X-Shining Luciferase is suitable …
Ref: 3D-L-8095
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 14 May 2024
